Page last updated: 2024-09-03

h-d-phe-pip-arg-pna and Convalescence

h-d-phe-pip-arg-pna has been researched along with Convalescence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elikowski, W; Grzywacz, A; Przybyl, L; Turowiecka, Z; Vinazzer, H; Zawilska, K; Zozulinska, M	1

Trials

1 trial(s) available for h-d-phe-pip-arg-pna and Convalescence

Article	Year
On the action of a heparan-like glycosaminoglycan (Hemovasal) on the mechanism of haemostasis and fibrinolysis. Thrombosis research, 1995, May-01, Volume: 78, Issue:3 Topics: Administration, Oral; Adult; Anticoagulants; Antithrombin III; Circadian Rhythm; Convalescence; Dermatan Sulfate; Dipeptides; Fibrinolysis; Fibrinolytic Agents; Glycosaminoglycans; Hemostasis; Heparin; Heparin Cofactor II; Humans; Injections, Intramuscular; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Recurrence; Thrombin; Tissue Plasminogen Activator	1995

Article

Year

On the action of a heparan-like glycosaminoglycan (Hemovasal) on the mechanism of haemostasis and fibrinolysis.

Thrombosis research, 1995, May-01, Volume: 78, Issue:3

Topics: Administration, Oral; Adult; Anticoagulants; Antithrombin III; Circadian Rhythm; Convalescence; Dermatan Sulfate; Dipeptides; Fibrinolysis; Fibrinolytic Agents; Glycosaminoglycans; Hemostasis; Heparin; Heparin Cofactor II; Humans; Injections, Intramuscular; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Recurrence; Thrombin; Tissue Plasminogen Activator

1995